Study Finds Industry-funded Drug Trials Yield More Favorable Results

Drug trials funded by industry are more likely to report positive outcomes than are trials funded by other sources. They also are less likely to be published within two years of completion of the study. Those findings come from a study published in the Aug. 3 issue of Annals of Internal Medicine.